BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 2, 2003
View Archived Issues
124 Genes Of 9,600 Confirmed Four Permutations Of Two Cancer Drugs For Optimum Outcome
Read More
Epimmune Receives Boost From Merck Vaccine Deal
Read More
Other News To Note
Read More
Rib-X Raises $51M To Push Ribosome-Based Antibiotics
Rib-X Pharmaceuticals Inc. landed the year s third-largest private round of financing, reeling in $51 million in a Series B placement of preferred stock.(BioWorld Today)
Read More
Galileo Gets $31M To Advance Internal, Partnered Programs
Read More